Editas Medicine, Inc. (EDIT) Financials
EDIT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 440.3 million | 145.9 million |
| 2023-12-31 | 499.2 million | 150.1 million |
| 2023-09-30 | 504.7 million | 144.2 million |
| 2023-06-30 | 542.0 million | 142.0 million |
EDIT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -51.7 million | 7.6 million |
| 2023-12-31 | -23.5 million | 5.3 million |
| 2023-09-30 | -35.7 million | 4.7 million |
| 2023-06-30 | -40.0 million | 5.2 million |
EDIT Net Income
No data available :(
EDIT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 296.2 million | - | 34.1 million |
| 2023-12-31 | 323.1 million | - | 36.5 million |
| 2023-09-30 | 446.4 million | - | 34.6 million |
| 2023-06-30 | 480.0 million | - | 37.2 million |
EDIT Shares Outstanding
EDIT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 1.9 million | 47.4 million | 19.3 million | - |
| 2023-12-31 | 1.3 million | 68.1 million | 14.5 million | - |
| 2023-09-30 | 239000 | 5.3 million | 15.0 million | - |
| 2023-06-30 | 1.3 million | 29.8 million | 17.2 million | - |
EDIT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 1.1 million | 1.4 million |
| 2023-12-31 | 60.0 million | 1.5 million |
| 2023-09-30 | 5.3 million | 1.5 million |
| 2023-06-30 | 2.9 million | 1.5 million |
EDIT
Price: $5.17
52 week price:
Earnings Per Share: -2.07 USD
P/E Ratio: -2.67
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 2.6 million
Ebitda: -26.1 millionMarket Capitalization: 484.4 million